TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/29/22 14:34 | 12/27/22 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P.m | 9 | 1.54 | 0 | 6 | 22 | 33 | D | ||||||||||||||
3/28/22 16:31 | 3/24/22 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P | 51 | 3.40 | 0 | 15 | 126 | 27 | D | ||||||||||||||
9/22/21 18:51 | 9/21/21 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P | 32 | 6.32 | 0 | 5 | 73 | 12 | D | ||||||||||||||
9/13/21 16:37 | 9/9/21 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P | 50 | 8.48 | 0 | 6 | 589 | 7 | D | ||||||||||||||
7/22/21 07:37 | 7/20/21 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P | 15 | 15.00 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |